Ewelina Krzywinska
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.
Journal: Frontiers in immunology
Published: September 23, 2025
Vaccination-based immunotherapy to target profibrotic cells in liver and lung.
Journal: Cell stem cell
Published: May 11, 2025
The transcription factor HIF-1α in NKp46+ ILCs limits chronic intestinal inflammation and fibrosis.
Journal: Life science alliance
Published: January 13, 2024
Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas.
Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas.
Journal: EMBO molecular medicine
Published: October 20, 2023
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma.
Journal: Science advances
Published: January 13, 2023
Resting natural killer cell homeostasis relies on tryptophan/NAD+ metabolism and HIF-1α.
Journal: EMBO reports
Published: September 20, 2022
Vaccination-based immunotherapy to target profibrotic cells in liver and lung.
Journal: Cell stem cell
Published: April 11, 2022
The transcription factor HIF-1α mediates plasticity of NKp46+ innate lymphoid cells in the gut.
Journal: The Journal of experimental medicine
Published: April 28, 2021
NK cells in hypoxic skin mediate a trade-off between wound healing and antibacterial defence.
Journal: Nature communications
Published: October 16, 2020
Last Updated: 09/26/2026